Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | NA0739 | IM / LA |
| FLU3 | INFLUENZA (SEASONAL) (FLUAD) | SEQIRUS, INC. | 1 | 407257 | IM / RA |
Five minutes following vaccine administration client started experiencing burning in chest at/below nipple line in the center of her chest. Client expresses having anxiety, but that this felt different. She appeared uncomfortable and expressed concern. Her BP was 178/79 @ 1050, pulse 71, O2 96%. Taking deep breaths, but easy breathing. Client alert and color and skin is WNL. BP @ 1057 160/84, 62 pulse, O2 99%. BP @ 1100 148/79, pulse 60, respiratory rate 18, with O2 96%. 1107 BP @ 143/86, pulse 66, RR: 16 and O2 97%. Patient reports that evening (1700) she developed a high fever of 103 with horrendous headache and loss of urinary function throughout the night as fever persisted. Headache continued throughout the next day as well. She slept most of Saturday, beginning to feel better on Sunday, October 5th.